Fiona Lalloo

12.7k citations
181 papers · 9.6k · 7 hit papers · h-index 53

Impact in

Papers in

    • BRCA gene mutations in cancer 96
    • Genomic variations and chromosomal abnormalities 18
    • Cancer Genomics and Diagnostics 38

Fiona Lalloo

173 papers receiving 9.3k citations

Fiona Lalloo's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+5+10Years since publication200400600

Peers

Fiona Lalloo
Comparison fields: 5 of 160
  • Cancer Research 1.6k
  • Pathology and Forensic Medicine 2.0k
  • Genetics 3.0k
  • Neurology 1.0k
  • Oncology 1.8k
Replace Kathy Pritchard‐Jones with:
Kathy Pritchard‐Jones United Kingdom
Alfredo Hidalgo‐Miranda Mexico
Frederick P. Li United States
Rashmi K Chugh United States
Asta Försti Germany
Matthew L. Freedman United States
Deborah Ford United Kingdom
Lucy E. Side United Kingdom
Kathleen Claes Belgium
Fernando Augusto Soares Brazil
Fiona Lalloo relative to Kathy Pritchard‐Jones United Kingdom Kathy Pritchard‐Jones's profile →
Citations per field
00.5×2×2.5×
Kathy Pritchard‐Jones · 1×
Citations per year

Countries citing papers authored by Fiona Lalloo

Since Specialization
Citations

This map shows the geographic impact of Fiona Lalloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Lalloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Lalloo more than expected).

Fields of papers citing papers by Fiona Lalloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Lalloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Lalloo. The network helps show where Fiona Lalloo may publish in the future.

Co-authors

The 25 scholars most cited alongside Fiona Lalloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fiona Lalloo Line = papers co-authored together Fiona Lalloo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service
Hit paper breakdown →
2010737
2
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
3
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
4
Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG)
Hit paper breakdown →
2019325
5
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
6 2009281
7 2009257
8 2011247
9
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
10
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
11 2018189
12 2019188
13 2008181
14 2011176
15 2020174
16 2019172
17 2003162
18 2012150
19 1998140
20 2006139

About Fiona Lalloo

Fiona Lalloo is a scholar working on Genetics, Cancer Research, Pathology and Forensic Medicine, Oncology and Reproductive Medicine, having authored 181 papers that have together received 9.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (96 papers), Genetic factors in colorectal cancer (47 papers), Cancer Genomics and Diagnostics (38 papers), Genomic variations and chromosomal abnormalities (18 papers), Colorectal Cancer Screening and Detection (14 papers), Ovarian cancer diagnosis and treatment (12 papers), DNA Repair Mechanisms (12 papers) and Adrenal and Paraganglionic Tumors (8 papers). The work is most often cited by research in Cancer Research (1.6k citations), Pathology and Forensic Medicine (2.0k citations), Genetics (3.0k citations), Neurology (1.0k citations) and Oncology (1.8k citations). Fiona Lalloo has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include D. Gareth Evans, Tara Clancy, Anthony Howell, Andrew Shenton, Emma Roisin Woodward, James Hill, Susan Huson, Eamonn Richard Maher, Harrison C. Spencer and Clare Giblin. Their work appears in journals such as Journal of Medical Genetics, Familial Cancer, The Lancet, Genetics in Medicine and Clinical Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact